Published study
PANDA
- Clinical area
- Pancreatic cancer
- Imaging basis
- Non-contrast CT
- Publication context
- Nature Medicine, 2023
Australia-based AI-native technology company
From Frontier Intelligence to Real-World Impact
Cognis translates advanced artificial intelligence into institutionally deployable solutions, with Healthcare AI as the current flagship vertical.
How Cognis Creates Value
The Translation Layer Between Frontier AI and Real-World Adoption
Cognis moves advanced AI capabilities through the institutional pathway required for responsible use: access, translation, validation, deployment and scale.
ACCESS
01
Advanced AI capability
TRANSLATE
02
Institutional context
VALIDATE
03
Local evidence pathway
DEPLOY
04
Governed adoption
SCALE
05
Infrastructure impact
Our Flagship
Advancing Healthcare AI Infrastructure
Cognis is currently focused on Healthcare AI, with Medical Imaging AI as the primary priority. We explore how existing healthcare infrastructure can yield additional preventive and clinical value through responsible AI.
Medical Imaging AI
AI-enabled healthcare sensing
Clinician-assistive workflows
Signature Idea
One Scan, Multiple Insights
Routine CT imaging may contain information relevant to multiple disease areas. AI can help convert latent imaging value into structured, clinician-reviewable risk signals.
One existing examination can potentially surface multiple clinician-reviewable signals.
Evidence
Built on Evidence, Not Hype
The medical imaging AI capabilities associated with Cognis are supported by peer-reviewed studies involving multi-centre validation, reader studies and real-world consecutive CT cohorts.
Scientific Evidence Architecture
Published studies + validation depth + local translation
Published study
GRAPE
- Clinical area
- Gastric cancer
- Imaging basis
- Non-contrast CT
- Publication context
- Nature Medicine, 2025
Published study
iAorta
- Clinical area
- Acute aortic syndrome
- Imaging basis
- Non-contrast CT
- Publication context
- Nature Medicine, 2025
Validation Foundation
Published studies rest on validation depth and lead toward local translation and governance.
L1
Peer-reviewed publication
L2
Multi-centre validation
L3
Reader studies
L4
Real-world consecutive cohorts
L5
Local validation requirement
L6
Governance and regulatory-aware translation
Published evidence informs translation. Local validation remains essential. AI supports clinicians. It does not replace clinicians.
Why Cognis
More Than Model Access
Cognis is built to connect frontier technology with the institutions required for real-world adoption: researchers, clinicians, technology owners, regulators, government, industry and capital partners.
International technology connection
Australia-based validation pathway
Regulatory-aware commercialisation
Frontier AI
Institutional Adoption
Models
Research
Technology
Scientific AI
Cognis
Translation Layer
Evidence
Validation
Governance
Commercialisation
Hospitals
Universities
Research
Government
Industry
Capital
Cognis sits between advanced capability and institutional adoption, translating frontier intelligence into pathways that can be validated, governed and scaled.
Partnerships
Global Technology. Local Validation.
Cognis works with hospitals, universities, research institutions, technology partners, government, industry and investors to move advanced AI toward responsible adoption.
Global Technology
Advanced AI capability
Technology partners
Research-backed models
Australia Validation Environment
Current primary validation context
Universities
Research design · Ethics · Evidence generation
Hospitals
Workflow validation · Clinician feedback
Research institutions
Data analysis · Publication
Government
Public health · Governance
Industry
Deployment context · Operations
Capital
Commercialisation · Scale
Australia is the current primary validation environment. The architecture remains extensible for future international expansion.
Responsible Adoption
Responsible adoption pathways
Scale-ready infrastructure
Next Step
Partner With Cognis
We welcome conversations with institutions interested in Healthcare AI, frontier AI translation, local validation and responsible deployment pathways.